ArticleThe oncologist2017

Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.

Zong-Han Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.